Contract development and manufacturing organisation (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canada’s largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet form.
With over 70 years of opiate fully backward integrated production we can guarantee the highest quality and full control over the final product delivered to our customers.More Info
Contract development and manufacturing organisation (CDMO) Saneca Pharma has announced the appointment of its new CEO, Richard Král.
Held in New York March 19-22, 2018, Saneca’s Business Unit API will take part in this resource destination for thousands of industry professionals to network with colleagues, generate new business, and gain knowledge and valuable insight from our expert-led education programs. DCAT Week is the premier business development event for companies engaged in pharmaceutical development…
Do you want to attend?
+421 33 736 1111, email@example.com
The European pharmaceutical market is currently the fifth largest market in the continent, enjoying steady growth and regulatory progression.